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Chassalia curviflora is used in folklore medicines for treating several ailments and infections owing to its anti-
inflammatory properties. Though the plant has been reported to possess anti-inflammatory antihepatotoxic and analgesic 
activities, its anticancer potential has not been studied so far. In the present study, we investigated the antiproliferative effects 
of the total alkaloids isolated from the roots of C. curviflora. The total alkaloid was validated by MTT assay in three cancer 
cell lines, such as liver cancer cell line-A549, breast cancer cell line-MCF-7 and ovarian cancer cell line -HeLa. Significant 
antiproliferative effect (IC50 value 3.59±0.14*** µg/mL) was observed in A549 cells, and was taken for further studies. Cell 
cycle analysis showed that the cells got arrested in sub G0 phase and annexin V-FITC assay revealed that 27.4% cells were in 
early apoptosis and 7% cells in late apoptosis. The study revealed that the total alkaloids of Chassalia curviflora roots possess 
significant antiproliferative and apoptotic activity. 
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Immunomodulatory 
Cancer is a group of diseases with multistage process 
involving abrupt cell division. According to World 
Health Organization (WHO), cancer accounts for the 
second leading cause of deaths globally. Although 
there is an overall decrease of 27%, since 1991 
translating to approximately 2.6 million fewer cancer 
deaths, the cancer mortality rates of poor countries has 
increased to several folds during 2012-20161. It has 
been estimated that one third of the chemicals used in 
cancer chemotherapy are derived from natural 
products2,3. About 20.2% of anticancer agents 
approved during the period 1981-2010, were synthetic 
and the rest were natural products or inspired by natural 
products4. For developing new drug, plants are selected 
based on their ethnopharmacologic or ethnobotanic 
knowledge or by random selection of different plants. 
Various plant derived anticancer drugs like topotecan 
(hycamtin), irrinotecan (camptosar), vinblastin 
(velban), teniposide (VM-26) were approved for 
clinical use5. Induction of apoptosis is one of the most 
important effects of cytotoxic antitumor agents and is 
a major anti-cancer mechanisms of plant derived drugs. 
Herbal drugs can be classified as an immune-
modulatory drug or a chemopreventive medicine6. 
 
Both inflammation and infection are linked to 
cancer. There exists a strong correlation between the 
presence of inflammation and establishment, 
progression and aggressiveness of various 
malignancies7,8 Inflammation affects the immune-
survelliance as well as response of the body to therapy. 
Anti-inflammatory agents such as non-steroidal anti-
inflammatory drug (NSAID), steroids and natural 
products are widely used in the treatment of cancer. 
Immunomodulatory natural products can suppress 
inflammation and associated tumor progression and 
metastasis as well as alleviate pain9. The contribution 
of natural products towards drug development has been 
scientifically documented. The structural diversity and 
biological activity of natural products make them the 
most valuable sources of drugs and drug leads. 
 
The shrub Chassalia curviflora (Wall.) Thwaites 
[syn: Psychotria curviflora (Wall.)] belongs to the 
family Rubiaceae. The genus, commonly known as 
curved flower chasalis or curved flower woody 
chassalia, consists of more than 110 species with 
paleotropic distribution10. Chakma tribes of 
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Bangladesh apply crushed leaves on wounds11 for 
treating snake and insect bites, while Kani tribes of 
Agastyamalai, Kerala, India use roots as an effective 
medicine for treating jaundice12. In Peninsular 
Malaysia, root decoction is used to treat malaria, cough 
and remedy in phlegm, rheumatism and pneumonia13,14 
and both roots and leaves in combination are used to 
cure wounds, ulcers and to relieve headaches.  
 
Ethanolic extract of leaves and roots of C. curviflora 
were reported to possess anti-inflammatory, analgesic15, 
hepatoprotective activity16 and phytochemical analysis 
revealed that roots have high content of alkaloid. The 
alkaloids present in the Rubiaceae family principally 
contribute to their pharmacological activities. Anti-
inflammatory and immunomodulatory properties of a 
plant may contribute to its anticancer properties. 
Therefore, in this study, we tried to explore the 
antiproliferative activity of total alkaloid extracts of 
roots of Chassalia curviflora (Chr-alk) in vitro in 
cancer cells lines. 
 
Materials and Methods 
 
Plant material and extraction for alkaloids  
Roots of Chassalia curviflora (Walls) Thwaites 
were collected from the medicinal plant garden of 
University of Kerala. The plant was identified and a 
voucher specimen was deposited in the Herbarium of 
Jawaharlal Nehru Tropical Botanic Garden and 
Research Institute, (JNTBGRI), Palode, Kerala, India 
(TBGT 57053 23/9/11. Alkaloid extraction was carried 
out according to Maldoni17. The powdered root (400 g) 
was extracted with ethanol for 24 h in a continuous 
extraction soxhlet apparatus. This ethanolic extract 
(30.5 g) was concentrated in a rotary vacuum 
evaporator, acidified with 2 % hydrochloric acid, HCl 
(pH 1-2) for salt formation and partitioned with 
chloroform-water (3:1). The alkaloid salts in aqueous 
phase was treated with dilute ammonium chloride, 
NH4Cl (pH 9-10), to liberate tertiary alkaloids and 
partitioned in chloroform-water mixture. The organic 
layer was extracted until the last chloroform extract 
gave negative reaction for Dragendroff’s reagent. The 
extract was tested for the presence of alkaloids. The 
w/w yield of the extract was 3.5% and was labeled as 
Chr-alk. The presence of indole group in the alkaloid 
was tested by p-dimethylaminobenzaldehyde reagent, 
which gave purple colour18.  
 
Cell lines 
The human cancer cell lines A549, HeLa and MCF-7 
and normal cell line 3T3L1 were grown in DMEM 
supplemented with 10% fetal bovine serum with 2 mM 
L-glutamine, 100 units/mL penicillin and 100 µg/mL 
streptomycin. All media and supplements were 
purchased from GibcoTM, Thermo Fischer Scientific, 
Waltham MA. 
 
In vitro cytotoxic study –MTT assay  
The cytotoxic activity of the Chr-alk was carried out 
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) colorimetric assay according to 
Mossman19and evaluated against three cancer cell lines 
panels consisting of breast cancer (MCF-7), lung 
cancer (A549), cervix cancer (HeLa) and normal 
fibroblast cell (3T3 L1). The cells were routinely 
maintained as monolayer cell cultures in Dulbeco’s 
modified Eagle’s medium containing fetal bovine 
serum (10%), glutamine, penicillin/streptomycin. The 
cells were trypsinized and seeded in a 96-well plate at 
a density of 5×103 cells/well and incubated in a 
humidified atmosphere of 5% CO2 at 37C for 24 h. 
For treatment various concentrations of Chr-alk (0.05, 
0.1, 1, 5, 10, 25 μg/mL) were added and cells cultured 
in media alone served as positive control and media 
with DMSO as negative control. After 24 and 48 h time 
points, the medium was removed and cells were 
washed with PBS and fresh medium with MTT dye  
(5 mg/mL dissolved in PBS) was added. After 4 h of 
incubation in dark, the medium was removed, and 100 µL 
of isopropanol was added to each well to solubilize the 
formazan crystal and the optical density was measured 
at 570 nm in multiskanTM GO multiplate spectro-
photometer20. Results were taken from three 
independent experiments, each performed in 
triplicates. The percentage inhibition of proliferation 
was calculated using the formula given below and the 
IC50 values were determined from log-dose response 
curves using Graph pad prism software version 5 for 
windows. 
% Inhibition of proliferation =T/C×100, where 
T = Absorbance of test at 570 nm; and  
C = Absorbance of untreated control 
 
Detection of apoptosis 
 
Staining method: Acridine-ethidium bromide staining and Hoechst 
staining  
Apoptosis was detected in vitro by acridine orange-
ethidium bromide21 and Hoechst staining methods22. 
A549 cells were grown in a 6-well plate at a cell 
density of 5×105 cell/mL and then treated with Chr-alk 
(2.0, 3.5 µg/mL) for 48 h. For acridine orange-ethidium 
bromide staining, mixture (1:1) of AO and EtBr  
(4 µg/mL) solution was added to each well. For 




Hoechst staining, 100 µL of 10 mg/mL of Hoechst 
33342 was added to each well and incubated for 5 min. 
Stained cells were visualized by fluorescent 
microscopy at 350-460 nm. Nuclei of cells manifesting 
apoptosis were visualized with morphological features 
such as nuclear fragmentation and chromatin 
condensation and photographed. 
 
Cell cycle analysis  
A549 cells (1×106) were seeded in a 60 mm tissue 
culture dish and treated with Chr-alk (2.0, 3.5 µg/mL) 
for 48 h. After incubation at room temperature (25C), 
cells were trypsinized, pelleted and washed twice with 
ice cold PBS. It was suspended in ice-cold ethanol 
(70%) with gentle vortexing and kept in ice for 30 min. 
After incubation, the cells were washed with PBS and 
50 µL of RNase was added directly to the pellet 
followed by addition of 400 µL of propidium iodide 
(1.0 mg/mL). Mixed well and incubated in the dark for 
5-10 min. Cells were strained through a filter of 0.75 µM. 
Cell cycle distribution was analyzed using FACS 
Calibur (Becton-Dickinson)23. Data was analyzed 
using DIVA software program. 
 
Detection of apoptosis by annexin V-FITC assay  
Flow cytometric analysis were used to study the 
apoptotic cells24. Externalization of phosphatidyl 
serine is one of the indications of early stage of 
apoptosis. Annexin V-FITC quantitatively determines 
the percentage of cells within a population that are 
undergoing apoptosis24. Both apoptotic and necrotic 
cells from the same sample can be quantified apoptotic 
cells were quantified in A549 cells using Annexin V-
FITC apoptosis detection kit II (BD Biosciences, 
Pharmingen) according to manufacturer’s protocol. 
Briefly, A549 cells were treated with Chr-alk (2.0,  
3.5 µg/mL) for 48 h. Cells were trypsinized, pelleted, 
washed twice with ice cold PBS and suspended in  
100 µL 1X binding buffer at a concentration of  
(1×106 cells/mL). The cells were stained simultaneously 
with 5 µL FITC-conjugated annexin V and 5 µL PI. 
Gently vortexed the cells and incubated for 15 min at 
room temperature in the dark. To each tube 400 µL of 
binding buffer was added. The cells were analyzed 




The results were expressed as the mean±S.D. of 
triplicate experiments. Statistical analysis was done by 
oneway ANOVA using Graph Pad Prism software and 




Alkaloid-rich extract (Chr-alk) is cytotoxic to cancer cells 
The cytotoxic effect of the alkaloid rich extract 
(Chr-alk) on cancer cell lines was assessed by MTT 
assay. There was a concentration and time dependent 
increase in the percentage of cytotoxicity in MCF7 
(Fig. 1A), A549 cells (Fig. 1B) HeLa (Fig. 1C) and 
3T3L1 (Fig.1D) (P <0.001). There was more cell death 
treatment of extract on in A549 lung cancer cells with 
an IC50 value of 3.59±0.14 µg/mL (Table 1). The Chr-
alk induced less toxicity in normal cells compared to 
cancer cells showing its specificity to cancer cells. The 
IC50 values were determined after 24 and 48 h of 
treatment. 
 
Chr-alk induced apoptosis in cancer cells 
Dual staining by acridine orange/ethidium bromide 




Fig. 1 — Cytotoxic assay (MTT) of Chr-alk on (A) MCF7 cells; (B) A549cells; (C) HeLa cells; and (D) 3T3L1 cells. [Three trials were 
done with thee replicate for each concentration. Data were expressed as ± SD by one way ANOVA using Graph Pad Prism software and P 
<0.001 was considered as statistically significant] 
 
 
Table 1 — IC50 µg/mL values of Chassalia curviflora root 
alkaloid extract (Chr-alk) on different cell lines 
Cell Lines IC50 (µg/mL) 
24 h 48 h 
MCF7 15.6±0.12** 6.488± 1.23*** 
A549 8.26±0.152*** 3.59± 0.14*** 
HeLa 12.56±0.05** 5.64±0.98*** 
[Values are expressed as mean ±SD by one way ANOVA using 
Graph Pad Prism software and P <0.001 was considered as 
statistically significant compared to negative control] 
 




as nuclear fragmentation, chromatin condensation and 
membrane blebbing after 48 h of treatment with Chr-
alk in A549 cells (Fig. 2 A-D). Viable cells appeared 
as green and apoptotic cells appeared as orange red. 
Hoechst staining revealed a greater intensity of blue 
colour in the treated cell compared to the untreated 
control cell, revealing condensed chromatin which is 
the major characteristic feature of apoptosis as shown 
in Fig. 3 (A-D). There was a concentration dependent 
increase in the percentage of apoptotic cells after 48 h 
of incubation. Microscopic studies to determine the 
growth inhibitory activities of Chr-alk by acridine 
orange-ethidium bromide dual staining and Hoechst 
staining revealed that Chr-alk induced morphological 
changes characteristic of apoptosis. Cells with 
chromatin condensation and nuclear fragmentation 
observed during the study clearly suggest apoptosis. 
 
Cell cycle analysis 
In the cell cycle analysis, it was found that cells 
were arrested in the sub G0 phase. A549 treated with 
Chr-alk (3.5 μg/mL), got arrested in sub G0 (Fig. 4 A-D) 
while 9.7% of cells were found to be in sub G0 phase, 
in control cultures only 2.5% of cells were in sub G0. 




Fig. 2 — Fluorescent microscopic images of acridine orange-ethidium bromide dual stained A549 cells for visualization of apoptotic cells 
(A) Untreated cells; (B) Cells treated with Chr-alk (2.0 μg/mL); (C) Cells treated with Chr-alk (3.5 μg/mL); and (D) Data on number of 
apoptotic cells of A549 treated with Chr-alk 2.0 μg/mL) and Chr-alk 3.5 μg/mL). [A single field of 60 cells were counted for apoptotic/dead 




Fig. 3 — Fluorescent microscopic images of Hoechst stained A549 cells for visualization of apoptotic cells (A) Untreated cells; (B) Cells 
treated with Chr-alk (2.0 μg/mL); (C) Cells treated with Chr-alk (3.5 μg/mL); and (D) Data on number of apoptotic cells of A549 treated 
with Chr-alk 2.0 μg/mL) and Chr-alk 3.5 μg/mL). [A single field of 80 cells were counted for apoptotic/dead and live cells three times 




Fig 4 — Effect of Chr-alk treatment on the cell cycle of A549 cells. (A) Untreated A549; (B) A549 treated with Chr-alk (2.0 μg/mL); (C) A549 
treated with Chr-alk (3.5 μg/mL); and (D) Cell cycle data of A549 cells after 48 h of treatment with Chr-alk at 2.0 and 3.5 μg/m. [Both control and 
treated cells after 48 h, were collected and stained with PI staining followed by FACS analysis The histogram shows there is an increase in subGo 
cells in both treatments compared to that of control. Chr-alk significantly (P <0.001) arrested cell cycle at sub G0 phase] 
 




apoptosis with 9.0% of cells in sub G0. In cells treated 
with Chr-alk (3.5 μg/mL), 11.7% of cells also got 
arrested in G2 phase (Fig. 4D). The percentage of cells 
in sub G0 phase arrest undergoing apoptosis was 
determined by annexin V-FITC staining. 
 
After exposure to Chr-alk (3.5 µg/mL for 48 h), 
proportion of early and late apoptotic cells increased 
significantly (P <0.001) as compared with control cells 
(Fig. 5A) with values of about 27.4% (Early apoptosis) 
and 7% (late apoptosis) (Fig. 5C). Chr-alk exerted 
significant early phase apoptotic effects by 
translocating phosphatidyl serine from inner to outer 
membrane. Lower concentration of Chr -alk did not 
give much apoptosis (Fig. 5B). The apoptosis index 
was quantitated by Annexin V-FITC assay and showed 
significant induction of early apoptosis against A549 




The present study demonstrated the potential effects 
of alkaloid extract of Chassalia curviflora (Chr-alk) on 
the viability and apoptosis of cancer cell lines. The 
extract reduced cell viability in a concentration 
dependent pattern as shown in MTT studies. All the 
three cell lines (MCF-7, HeLa and A549) used in the 
study responded to Chr-alk, independent of their 
lineage origin, with significant inhibition of growth. 
A549 cell line was significantly more sensitive to Chr-
alk with an IC50 value of 3.59±0.14 μg/mL. Chr-alk 
induced less toxicity in normal adipocyte cell line, 
3T3L, compared to cancer cells. Cancer cells being fast 
proliferating are more vulnerable to drugs compared to 
normal cells25.  
One of the factors regulating the population size of 
a clone is the induction of programmed cell death 
known as apoptosis, a highly regulated process that 
occurs as part of differentiation, proliferation and 
growth of normal and malignant cells and is 
characterized by morphological feature and DNA 
fragmentation. Microscopic studies to determine the 
grown inhibitory activities of Chr-alk by acridine 
orange-ethidium bromide dual staining and Hoechst 
staining revealed that Chr-alk induced morphological 
changes characteristic of apoptosis. There was a 
concentration dependent increase in the percentage of 
apoptotic cells after 48 h of incubation. Cells with 
chromatin condensation and nuclear fragmentation 
observed during the study clearly suggest 
apoptosis26,27.  
Cancers and many other human diseases are known 
as cell cycle disease due to the fact that many of 
regulatory factors of checkpoints are arrested or lost in 
tumorigenesis28. In this study, cell cycle analysis 
showed that increase in percentage of cell in sub G0 
compared to the control cells, while 9.7% of cells were 
found to be in sub G0 phase, in control cultures only 
2.5% of cells were in sub G0. This indicates that Chr-
alk induced cell arrest at the sub G0 phase in a dose 
dependent manner, an Chr-alk arrested cells at sub G0 
by inhibiting protein kinase complex consisting of 
cyclin and cyclin dependent kinase. It prevented DNA 
synthesis in cells. Thus, Chr-alk could act even at the 




Fig. 5 — Flow Cytometric Analysis of FITC annexin V staining of A549 (A) control cells; (B) A549 cells treated with Chr-alk (2.0 µg/mL); 
(C) A549 cells treated with Chr-alk (3.5 µg/mL); and (D) Data on Percentage of Apoptotic cells of A549 cells treated with Chr-alk  
(3.5 µg/ml) after 48 h. [Significant increase (P <0.001) marked by asterisks in percentage distribution of cells were observed] 
 




proliferation. The apoptosis ratio induced by Chr-alk 
was further quantitatively assessed by annexin V-FITC 
assay where the extract showed significant apoptosis 
induction against A549 cells. It was found that 34.4% 
of cells had undergone apoptosis. The annexin V assay 
also confirmed the ability of Chr-alk to induce early 
apoptosis. Correlation between cell cycle arrest and 
apoptosis has been well established29. Apoptosis acts 
as a protective mechanism by removing ailing cells and 
thereby maintaining homeostasis. 
Cancer cells shows resistance to apoptosis and 
thereby sustains uncontrolled proliferation of cells, 
therefore, any apoptosis modulating compound can act 
as a plausible chemotherapeutic agent against cancer 
cells30. Several natural products are in the standard 
repertoire of cancer therapy31 and alkaloids are among 
the most promising chemotherapeutic agent32. Our 
above findings reveal that alkaloid rich extract of roots 
of C. curviflora is a strong inducer of early apoptosis 
and cell cycle arrest in A549 lung cancer cells. 
 
Conclusion 
The alkaloid rich extracts of roots of Chassalia 
curviflora exhibited significant antiproliferative as 
well as apoptotic effects on cancer cell lines and 
significant cytotoxicity was observed on A549 cell line 
with an IC50 value of 3.59±0.14 μg/mL. The cell cycle 
analysis and Annexin V-FITC assay revealed that Chr-
alk induced early apoptosis in 34.4% cells. Bioactive 
phytochemicals with antioxidant, anti-inflammatory 
properties are potential leads to chemopreventive and 
chemoprotective activity. The anti-inflammatory and 
immunomodulatory roles of C. curviflora might have 
contributed to its anti-proliferative effects. Further 
studies are required to identify the major alkaloids 
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